This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Pfizer Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Pawel Kamil Dominik: Innovator in Antibody Development
Introduction
Pawel Kamil Dominik is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Pawel Kamil Dominik holds a patent for "Antibodies specific for CD47, PD-L1, and uses thereof." This patent includes antibodies that specifically bind to CD47 and PD-L1, as well as CD47/PD-L1 bispecific antibodies. The patent also outlines various uses of these antibodies, along with related compositions and methods. He has 1 patent to his name.
Career Highlights
Dominik is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Throughout his career, Pawel has collaborated with esteemed colleagues, including Thomas John Van Blarcom and Shih-Hsun Chen. These collaborations have further enhanced his research and contributed to the advancement of antibody therapies.
Conclusion
Pawel Kamil Dominik is a prominent figure in the field of antibody research, with a focus on developing innovative solutions for healthcare. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile